- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07766395
A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall Wellness
This study will evaluate the effects of Clean Nutra's Shelf Builder Women's Creatine Powder on lean muscle development, hormone-related wellness, digestive comfort, dermatological health, and overall wellness. The study is a single-arm, open-label, virtual trial in which all 35 enrolled participants will use the test product once daily for eight weeks.
Participants will complete self-reported questionnaires at Baseline and at the end of Week 4 and Week 8 to assess changes in lean muscle development, muscular endurance, hormone-related wellness, digestive comfort, hair/nail/skin health, and overall wellness.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Patrick Renner
- E-mail: hello@citruslabs.com
Lieux d'étude
-
-
Nevada
-
Las Vegas, Nevada, États-Unis, 89101
- Recrutement
- Citruslabs
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Be female.
- Be aged 21-45.
- Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, (e.g., running, gym/strength training, cycling, team sports, fitness classes).
- Anyone with a menstrual cycle between 24-38 days.
- Anyone who has experienced concerns with at least two of the following, twice per week, over the past four weeks: Hair, skin, and nail health
- Bloating
- Symptoms of hormonal imbalance.
- Anyone with a BMI of 18.5 to 30 kg/m2.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- If taking medications, other supplements, or herbal remedies targeted at lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health, has been consistently taking for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
- Anyone who is willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
- Resides in the United States.
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and mental health disorders.
- Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
- Planning on introducing any products or any new forms of prescription medication or supplements that target lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health for the study duration.
- Anyone who has been diagnosed with kidney disease and/or has previously or is currently taking diuretics or kidney medications.
- Anyone who has previously or is currently taking any hormone therapies.
- Anyone who is currently taking medications or supplements that contain zinc or iron.
- Anyone with any allergies or sensitivities to fish, eggs, or any of the study product ingredients.
- Anyone currently consuming products with creatine.
- Anyone diagnosed with a thyroid-related condition.
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- Anyone who has a history of serious illness in the last three months.
- Anyone who has planned surgery during the study period.
- Anyone with a history of substance abuse.
- Anyone who is currently a smoker or has been a smoker in the past 3 months.
- Anyone who has stopped or started using hormonal birth control in the past 2 months.
- Anyone who is vegan and/or does not consume animal products for any reason.
- Anyone currently taking a weight loss medication, including but not limited to Wegovy, Mounjaro, and Ozempic.
- Currently undergoing hair treatment or using other hair growth/thickening products.
- Currently taking any prescription medication for hair loss.
- Anyone with any conditions that affect the hair or scalp (e.g., alopecia areata).
- Anyone who drinks heavily (8 or more alcoholic drinks per week).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Shelf Builder Women's Creatine Powder
|
All participants take one scoop (9 g) of Clean Nutra Shelf Builder Women's Creatine Powder mixed in 8 oz of cold water once daily with the first meal of the day for eight weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Lean Muscle Development
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in lean muscle development assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Muscular Endurance
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in muscular endurance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Digestive Comfort
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in digestive comfort assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Hair
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Nail
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Skin Health
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in hair, nail, and skin health assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Symptoms of Hormonal Imbalance
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in symptoms of hormonal imbalance assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
|
Change in Overall Health and Wellness
Délai: Baseline, Week 4, and Week 8
|
Self-reported change in overall health and wellness assessed via questionnaire
|
Baseline, Week 4, and Week 8
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Perceived Change in Lean Muscle Strength
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle strength assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Exercise Performance
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in exercise performance assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Lean Muscle Development
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in lean muscle development assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Hair
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Nail
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Skin Health
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in hair, nail, and skin health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mood
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in mood assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Energy Levels
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in energy levels assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Mental Clarity
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in mental clarity assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Health
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive health assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Bloating
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in bloating assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Digestive Comfort
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in digestive comfort assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
|
Perceived Change in Muscle Recovery
Délai: Baseline, Week 4, and Week 8
|
Participant-perceived change in muscle recovery assessed via self-reported questionnaire
|
Baseline, Week 4, and Week 8
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 20834
- legacy-20834
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .